Sarcopenia as a public health problem
Sarcopenia as a public health problem
复制标题
DOI：
10.1016/j.eurger.2015.12.002
复制
发表时间：
2016-06-01
影响因子：
3.8
通讯作者：
Reginster, J. -Y.
中科院分区：
文献类型：
--
作者：
Bruyere, O.;Beaudart, C.;Reginster, J. -Y.
一个健康问题的重要性取决于其目前和预期的流行程度、临床和经济后果、受该问题影响的人的社会地位以及有效治疗的可得性。在本文中，我们回顾了目前关于肌肉减少症的主要文献，以评估这种老年综合征是否可以被视为一个主要的公共卫生问题。我们的综述强调，基于其患病率、临床后果、现有治疗方法的局限性以及许多体弱患者受这种老年综合征影响的事实，所有相关方都应将肌肉减少症视为健康优先事项，以减轻其负担。(C) 2015 Elsevier Masson SAS和欧盟老年医学学会。版权所有。
The importance of a health problem is based on its current and expected prevalence, its clinical and economic consequences, the social status of people affected by the problem and the availability of an effective treatment. In this paper, we review the main current literature on sarcopenia in order to assess whether this geriatric syndrome could be considered as a major public health problem. Our review highlights that based on its prevalence, its clinical consequences, the limitations of the current available treatments as well as on the fact that many frail patients are affected by this geriatric syndrome, sarcopenia should be considered as a health priority by all interested parties in order to reduce its burden. (C) 2015 Elsevier Masson SAS and European Union Geriatric Medicine Society. All rights reserved.